DrugCite
Search

CERTICAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Certican Adverse Events Reported to the FDA Over Time

How are Certican adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Certican, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Certican is flagged as the suspect drug causing the adverse event.

Most Common Certican Adverse Events Reported to the FDA

What are the most common Certican adverse events reported to the FDA?

Pyrexia
410 (3.14%)
Blood Creatinine Increased
306 (2.34%)
Diarrhoea
197 (1.51%)
Dyspnoea
168 (1.29%)
Oedema Peripheral
145 (1.11%)
Pneumonia
145 (1.11%)
Renal Impairment
144 (1.1%)
Kidney Transplant Rejection
130 (1%)
Concomitant Disease Progression
116 (.89%)
Abdominal Pain
110 (.84%)
Renal Failure Acute
106 (.81%)
Show More Show More
Anaemia
105 (.8%)
Transplant Rejection
102 (.78%)
Leukopenia
93 (.71%)
Nausea
93 (.71%)
Vomiting
93 (.71%)
Cough
90 (.69%)
Sepsis
82 (.63%)
Pain
81 (.62%)
Proteinuria
81 (.62%)
Cytomegalovirus Infection
80 (.61%)
Drug Ineffective
80 (.61%)
Interstitial Lung Disease
78 (.6%)
C-reactive Protein Increased
74 (.57%)
Arthralgia
72 (.55%)
Haemoglobin Decreased
72 (.55%)
Deep Vein Thrombosis
67 (.51%)
Lung Disorder
64 (.49%)
Asthenia
63 (.48%)
Fatigue
63 (.48%)
Renal Tubular Necrosis
63 (.48%)
Urinary Tract Infection
63 (.48%)
Coronary Artery Disease
61 (.47%)
Malaise
61 (.47%)
Nephropathy Toxic
61 (.47%)
Renal Failure
60 (.46%)
Immunosuppressant Drug Level Increa...
59 (.45%)
Impaired Healing
59 (.45%)
Lymphocele
59 (.45%)
Dehydration
58 (.44%)
Pancytopenia
58 (.44%)
Stomatitis
57 (.44%)
Pulmonary Embolism
56 (.43%)
Thrombocytopenia
56 (.43%)
Disease Progression
51 (.39%)
Respiratory Failure
51 (.39%)
Heart Transplant Rejection
50 (.38%)
Complications Of Transplanted Kidne...
49 (.38%)
Pleural Effusion
48 (.37%)
Surgery
48 (.37%)
Neutropenia
46 (.35%)
Escherichia Urinary Tract Infection
45 (.34%)
Headache
44 (.34%)
Hypotension
44 (.34%)
Weight Decreased
43 (.33%)
Aphthous Stomatitis
41 (.31%)
Drug Interaction
40 (.31%)
Dysuria
40 (.31%)
Blood Urea Increased
39 (.3%)
Liver Transplant Rejection
39 (.3%)
Pain In Extremity
39 (.3%)
Pericardial Effusion
39 (.3%)
Incisional Hernia
38 (.29%)
Diabetes Mellitus
37 (.28%)
Febrile Neutropenia
37 (.28%)
Gait Disturbance
37 (.28%)
Liver Function Test Abnormal
37 (.28%)
Renal Failure Chronic
37 (.28%)
Skin Ulcer
37 (.28%)
Lung Infiltration
36 (.28%)
Cholestasis
35 (.27%)
Gastroenteritis
35 (.27%)
Oedema
35 (.27%)
Septic Shock
35 (.27%)
Osteonecrosis
34 (.26%)
Pneumocystis Jiroveci Pneumonia
34 (.26%)
Pneumonia Bacterial
33 (.25%)
Enterococcal Infection
32 (.25%)
Erythema
32 (.25%)
Hepatic Enzyme Increased
32 (.25%)
Lymphoma
31 (.24%)
Hydronephrosis
30 (.23%)
Nephropathy
30 (.23%)
Tubulointerstitial Nephritis
30 (.23%)
Chest Pain
29 (.22%)
Decreased Appetite
29 (.22%)
Epstein-barr Virus Infection
29 (.22%)
Haematuria
29 (.22%)
Hypercholesterolaemia
29 (.22%)
Infection
28 (.21%)
Myalgia
28 (.21%)
Anaemia Postoperative
27 (.21%)
Bacterial Infection
27 (.21%)
Cardiac Failure
27 (.21%)
General Physical Health Deteriorati...
27 (.21%)
Inflammation
27 (.21%)
Multi-organ Failure
27 (.21%)
Respiratory Distress
27 (.21%)
Alanine Aminotransferase Increased
26 (.2%)
Back Pain
26 (.2%)
Cellulitis
26 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Certican, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Certican is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Certican

What are the most common Certican adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Certican, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Certican is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Certican According to Those Reporting Adverse Events

Why are people taking Certican, according to those reporting adverse events to the FDA?

Renal Transplant
1082
Heart Transplant
338
Liver Transplant
238
Prophylaxis Against Transplant Reje...
66
Immunosuppression
47
Lung Transplant
46
Show More Show More
Congenital Cystic Kidney Disease
36
Transplant
14
Metastatic Neoplasm
11
Product Used For Unknown Indication
8
Renal Cancer
7
Neuroendocrine Tumour
7
Renal Cell Carcinoma
6
Organ Transplant
6
Drug Use For Unknown Indication
6
Chronic Allograft Nephropathy
5
Metastatic Renal Cell Carcinoma
4
Liver Transplant Rejection
4
Neuroendocrine Carcinoma
3
Acute Myeloid Leukaemia
3
Nephropathy
3
Transplant Rejection
3
Coronary Artery Bypass
2
Ovarian Cancer
2
Graft Versus Host Disease
2
Stem Cell Transplant
2
Insulinoma
2
Drug Toxicity
2
Prophylaxis
2
Breast Cancer
2
Renal Cancer Metastatic
2
Immunosuppressant Drug Therapy
2
Kidney Transplant Rejection
2
Nephropathy Toxic
2
Hepatic Neoplasm Malignant
1
Idiopathic Thrombocytopenic Purpura
1
Renal Impairment
1
Kaposis Sarcoma
1
Prophylaxis Against Graft Versus Ho...
1
Lung Adenocarcinoma
1
Bk Virus Infection
1
Corneal Transplant
1
Squamous Cell Carcinoma
1
Diarrhoea
1
Hodgkins Disease
1
Tuberous Sclerosis
1
Transplant Failure
1
Metastatic Carcinoid Tumour
1
Skin Cancer
1
Glioblastoma Multiforme
1
Idiopathic Pulmonary Fibrosis
1

Certican Case Reports

What Certican safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Certican. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Certican.